Search

Author/Creator Cimino-Mathews, Ashley

1. A phase I study of the PD-L1 inhibitor, durvalumab, in combination with a PARP inhibitor, olaparib, and a VEGFR1–3 inhibitor, cediranib, in recurrent women's cancers with biomarker analyses. Issue 1 (25th July 2019)

Authors:
Zimmer, Alexandra S.; Nichols, Erin; Cimino-Mathews, Ashley; Peer, Cody; Cao, Liang; Lee, Min-Jung; Kohn, Elise C.; Annunziata, Christina M.; Lipkowitz, Stanley; Trepel, Jane B.; Sharma, Rajni; Mikkilineni, Lekha; Gatti-Mays, Margaret; Figg, William D.; Houston, Nicole D.; Lee, Jung-Min
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 7:Issue 1(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Assessment of PD-L1 expression across breast cancer molecular subtypes, in relation to mutation rate, BRCA1-like status, tumor-infiltrating immune cells and survival. (2nd December 2018)

Authors:
Sobral-Leite, Marcelo; Van de Vijver, Koen; Michaut, Magali; van der Linden, Rianne; Hooijer, Gerrit K.J.; Horlings, Hugo M.; Severson, Tesa M.; Mulligan, Anna Marie; Weerasooriya, Nayana; Sanders, Joyce; Glas, Annuska M; Wehkamp, Diederik; Mittempergher, Lorenza; Kersten, Kelly; Cimino-Mathews, ...
Journal:
Oncoimmunology
Issue:
Volume 7:Number 12(2018)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Clinical outcomes of prexasertib monotherapy in recurrent BRCA wild-type high-grade serous ovarian cancer involve innate and adaptive immune responses. Issue 2 (23rd July 2020)

Authors:
Lampert, Erika J; Cimino-Mathews, Ashley; Lee, Joo Sang; Nair, Jayakumar; Lee, Min-Jung; Yuno, Akira; An, Daniel; Trepel, Jane B; Ruppin, Eytan; Lee, Jung-Min
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8:Issue 2(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Clinical outcomes of prexasertib monotherapy in recurrent BRCA wild-type high-grade serous ovarian cancer involve innate and adaptive immune responses. Issue 2 (23rd July 2020)

Authors:
Lampert, Erika J; Cimino-Mathews, Ashley; Lee, Joo Sang; Nair, Jayakumar; Lee, Min-Jung; Yuno, Akira; An, Daniel; Trepel, Jane B; Ruppin, Eytan; Lee, Jung-Min
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8:Issue 2(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Clinical outcomes of prexasertib monotherapy in recurrent BRCA wild-type high-grade serous ovarian cancer involve innate and adaptive immune responses. Issue 2 (23rd July 2020)

Authors:
Lampert, Erika J; Cimino-Mathews, Ashley; Lee, Joo Sang; Nair, Jayakumar; Lee, Min-Jung; Yuno, Akira; An, Daniel; Trepel, Jane B; Ruppin, Eytan; Lee, Jung-Min
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8:Issue 2(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Clinical outcomes of prexasertib monotherapy in recurrent BRCA wild-type high-grade serous ovarian cancer involve innate and adaptive immune responses. Issue 2 (23rd July 2020)

Authors:
Lampert, Erika J; Cimino-Mathews, Ashley; Lee, Joo Sang; Nair, Jayakumar; Lee, Min-Jung; Yuno, Akira; An, Daniel; Trepel, Jane B; Ruppin, Eytan; Lee, Jung-Min
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8:Issue 2(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Clinical outcomes of prexasertib monotherapy in recurrent BRCA wild-type high-grade serous ovarian cancer involve innate and adaptive immune responses. Issue 2 (23rd July 2020)

Authors:
Lampert, Erika J; Cimino-Mathews, Ashley; Lee, Joo Sang; Nair, Jayakumar; Lee, Min-Jung; Yuno, Akira; An, Daniel; Trepel, Jane B; Ruppin, Eytan; Lee, Jung-Min
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8:Issue 2(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Clinical outcomes of prexasertib monotherapy in recurrent BRCA wild-type high-grade serous ovarian cancer involve innate and adaptive immune responses. Issue 2 (23rd July 2020)

Authors:
Lampert, Erika J; Cimino-Mathews, Ashley; Lee, Joo Sang; Nair, Jayakumar; Lee, Min-Jung; Yuno, Akira; An, Daniel; Trepel, Jane B; Ruppin, Eytan; Lee, Jung-Min
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8:Issue 2(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Clinical outcomes of prexasertib monotherapy in recurrent BRCA wild-type high-grade serous ovarian cancer involve innate and adaptive immune responses. Issue 2 (23rd July 2020)

Authors:
Lampert, Erika J; Cimino-Mathews, Ashley; Lee, Joo Sang; Nair, Jayakumar; Lee, Min-Jung; Yuno, Akira; An, Daniel; Trepel, Jane B; Ruppin, Eytan; Lee, Jung-Min
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8:Issue 2(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗